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ABSTRACT
Tumor necrosis factor (TNF)- has been reported to mod-
ulate brain injury, but remarkably, little is known about its
effects on neurogenesis. We report that TNF- strongly
influences survival, proliferation, and neuronal differen-
tiation in cultured subventricular zone (SVZ) neural
stem/progenitor cells derived from the neonatal P1–3
C57BL/6 mice. By using single-cell calcium imaging, we
developed a method, based on cellular response to KCl
and/or histamine, that allows the functional evaluation of
neuronal differentiation. Exposure of SVZ cultures to 1
and 10 ng/ml mouse or 1 ng/ml human recombinant
TNF- resulted in increased differentiation of cells dis-
playing a neuronal-like profile of [Ca2]i responses, com-
pared with the predominant profile of immature cells
observed in control, nontreated cultures. Moreover, by
using neutralizing antibodies for each TNF- receptor,
we found that the proneurogenic effect of 1 ng/ml TNF-
is mediated via tumor necrosis factor receptor 1 activa-
tion. Accordingly, the percentage of neuronal nuclear
protein-positive neurons was increased following expo-
sure to mouse TNF-. Interestingly, exposure of SVZ
cultures to 1 ng/ml TNF- induced cell proliferation,
whereas 10 and 100 ng/ml TNF- induced apoptotic cell
death. Moreover, we found that exposure of SVZ cells to
TNF- for 15 minutes or 6 hours caused an increase in the
phospho-stress-activated protein kinase/c-Jun N-terminal
kinase immunoreactivity initially in the nucleus and then
in growing axons, colocalizing with tau, consistent with axono-
genesis. Taken together, these results show that TNF- induces
neurogenesis in neonatal SVZ cell cultures of mice. TNF-, a
proinflammatory cytokine and a proneurogenic factor, may
play a central role in promoting neurogenesis and brain repair
in response to brain injury and infection. STEM CELLS 2008;
26:2361–2371
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INTRODUCTION
In the adult brain, neurogenesis occurs constitutively in two
defined regions: the subgranular zone of the hippocampus and
the subventricular zone (SVZ) lining the lateral ventricles. Neu-
ral stem cells (NSCs) located in the SVZ proliferate and give
rise to neuroblasts that migrate toward the olfactory bulb, where
they differentiate into interneurons [1–5]. This robust process,
giving rise to a constant neuronal replacement of olfactory
interneurons, highlights the potential of SVZ cells for future
stem cell-based brain repair strategies.
Upon brain injury, newly generated neuroblasts migrate out
of the SVZ toward the damaged areas of the brain [6–12].
Injury-enhanced neurogenesis relies in part on soluble mediators
released by damaged tissue and activated immune cells. In
particular, inflammatory cytokines, abundantly secreted follow-
ing brain injury or infection, may influence neurogenesis [13–
16]. Among these inflammatory mediators, tumor necrosis fac-
tor (TNF)- is a crucial effector of immune responses in the
brain [17, 18], mediating distinct cellular effects through two
different receptors: tumor necrosis factor receptor (TNFR) 1,
which contains an intracellular “death domain” and contributes
mainly to neuronal death, and TNFR2, which contributes mainly
to neuroprotection [19–22]. Recent reports suggest that TNF-
can also modulate neurogenesis. Indeed, neural stem/progenitor
cells express TNF- [23, 24] and its receptors [24–28].
It has been reported that TNF- regulates survival of NSCs.
However, recent studies have shown that TNF- contributes to
the death of hippocampal progenitor cells [26] and mouse-
derived SVZ neurospheres in vitro [29]. In contrast, few apo-
ptotic cells were found in the SVZ of TNF--treated rats, where
an increase in proliferation was observed in vivo in basal con-
ditions [30]. Moreover, in vivo infusion of a neutralizing anti-
body against TNF- reduced the number of new striatal and
hippocampal neuroblasts generated after stroke [31].
Several lines of evidence have also implicated TNF- in
proliferation of NSCs in the intact and in the injured brain. In
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particular, it has been shown that mice lacking TNF- had a
significant reduction of the pool of proliferating oligodendro-
cytes and a subsequent delay in remyelination in a mouse model
of demyelinating diseases [32]. Furthermore, Widera et al. [28]
showed that nuclear factor B and cyclin D1 play a crucial role
in the proliferation of NSCs induced by TNF- in vitro. How-
ever, TNF- was found to inhibit proliferation of TNFR1-
expressing striatal neural progenitors in vitro [25]. In accor-
dance, by using mice lacking TNF- receptors, Iosif et al.
showed that TNFR1 acts as a suppressor of progenitor prolifer-
ation both under basal conditions and after onset of status
epilepticus, whereas TNFR2 can improve survival of the newly
formed neurons in the pathological brain in vivo [24]. More-
over, TNF- was shown to stimulate neuronal differentiation of
immature neural cells and neuroblastoma cell lines infected with
HIV-1 [33, 34].
In the present report, we dissect the effects of TNF- on
neurogenesis in mouse SVZ cultures by using a novel method
able to functionally discriminate neuronal differentiation. More-
over, we investigated the involvement of the stress-activated
protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) signaling
pathway in response to TNF- exposure and the interplay be-
tween cell death and proliferation. Taken together, our results
open a new perspective for TNF- as a proneurogenic factor,
able to facilitate neuronal replacement and brain repair in re-
sponse to brain injury.
MATERIALS AND METHODS
All experiments were performed in accordance with European
Union (86/609/EEC) guidelines for the care and use of laboratory
animals.
Subventricular Zone Cell Cultures
SVZ cells were prepared from 1–3-day-old C57BL/6 donor mice as
described by Agasse et al. [35]. Briefly, mice were killed by
decapitation, and the brains were removed and placed in calcium-
and magnesium-free Hanks’ balanced saline solution (Gibco, Rock-
ville, MD, http://www.invitrogen.com) under sterile conditions.
Fragments of SVZ were dissected out of 450-m-thick coronal
brain sections by using a McIlwain tissue chopper, and then SVZ
was digested in 0.025% trypsin (Gibco) and 0.265 mM EDTA
(Gibco) (10 minutes, 37°C), following by mechanical dissociation
with a P1000 pipette. The cell suspension was diluted in serum-free
medium (SFM) composed of Dulbecco’s modified Eagle’s medium
(DMEM) (DMEM/Ham’s F-12 medium  GlutaMAX-I) supple-
mented with 100 U/ml penicillin, 100 g/ml streptomycin, 1% B27
supplement, 10 ng/ml epidermal growth factor, and 10 ng/ml basic
fibroblast growth factor-2 (all from Gibco). Single cells were then
plated on uncoated Petri dishes at a density of 3,000 cells per cm2
and were allowed to develop in an incubator with 5% CO2 and 95%
atmospheric air at 37°C.
Six to 8 days after plating, the SVZ neurospheres were collected
and seeded onto poly-D-lysine (0.1 mg/ml)-coated glass coverslips,
placed into 12-well cell culture plates for single-cell calcium imag-
ing (SCCI) experiments or 24-well cell culture plates for immuno-
cytochemistry, and covered with 1 ml or 500 l, respectively, of
SFM devoid of growth factors. Then, SVZ neurospheres were
allowed to develop for 2 days with 5% CO2 and 95% atmospheric
air at 37°C before experimental treatments. A scheme of the pro-
tocol is provided in Figure 2A.
Experimental Treatments
To investigate the influence of TNF- on neuronal differentiation,
SVZ neurospheres were allowed to develop for 7 days with recom-
binant mouse (0.3, 1, 10, and 100 ng/ml; R&D Systems Inc.,
London, http://www.rndsystems.com) or human (1 ng/ml; Pepro-
tech, London, http://www.peprotech.com) TNF- at 37°C. To de-
termine which TNF- receptor was involved in the proneurogenic
effect, SVZ cells were treated with 1 ng/ml mouse TNF- together
with 20 g/ml neutralizing mouse monoclonal anti-TNFR1 or with
20 g/ml neutralizing mouse monoclonal anti-TNFR2 antibodies
[36] (both from R&D Systems). In a group of experiments, SVZ
cells were treated with a neutralizing antibody against TNF- (81
g/ml; Upstate Biotechnology, Lake Placid, NY, http://www.
upstate.com). At the end of treatments, SCCI experiments and
immunocytochemistry for neuronal markers (neuronal nuclear pro-
tein [NeuN] and microtubule associated protein-2 [MAP-2]) were
performed (Fig. 2A). To dissociate the apoptotic effect of TNF-,
SVZ cells were coincubated for 48 hours with 10 ng/ml TNF- and
25 M z-Val-Ala-DL-Asp (OMe)-fluoromethylketone (zVAD-fmk;
Calbiochem, Nottingham, U.K., http://www.emdbiosciences.com), a
pan-caspase inhibitor used as an antiapoptotic agent.
To investigate the involvement of the SAPK/JNK signaling
pathway in response to TNF- stimulation, SVZ neurospheres were
treated with 1, 10, or 100 ng/ml mouse recombinant TNF- for 15
minutes or 6 hours at 37°C. At the end of each incubation protocol,
immunocytochemistry against phosphorylated (activated) forms of
the SAPK/JNK kinase, namely P-SAPK/JNK, was performed (Fig.
2A). Each experiment included a series of control cultures not
subjected to any drugs.
Determination of Cell Apoptosis by Terminal
Deoxynucleotidyl Transferase dUTP Nick-End
Labeling
Cell apoptosis in SVZ cells was evaluated by the terminal deoxy-
nucleotidyl transferase dUTP nick-end labeling (TUNEL), essen-
tially as previously reported [35]. This method is based on the
specific activity of TdT, which attaches labeled nucleotides (dUTP)
to the 3-OH ends of the DNA generated during apoptotic-induced
DNA fragmentation [37]. At the end of each TNF- incubation
protocol (48 hours), SVZ cultures were fixed for 30 minutes in 4%
paraformaldehyde (PFA) at room temperature, rinsed in 0.15 M
phosphate-buffered saline (PBS; containing 137 mM NaCl, 2.7 mM
KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4), and permeabil-
ized in 0.25% Triton X-100 (Sigma-Aldrich, St. Louis, http://www.
sigmaaldrich.com) for 30 minutes at room temperature. Thereafter,
SVZ cultures were incubated for 20 minutes in 3% H2O2 and
reacted for terminal transferase (0.25 U/l) biotinylated dUTP (6
M) nick-end labeling of fragmented DNA in TdT buffer (pH 7.5)
(all from Roche, Basel, Switzerland, http://www.roche-applied-
science.com) for 1 hour 30 minutes at 37°C in a humidified cham-
ber. The enzymatic reaction was stopped by 15 minutes of incuba-
tion in 300 mM NaCl (Sigma-Aldrich) and 30 mM sodium citrate
(Sigma-Aldrich) buffer. Following an additional rinse in PBS, cul-
tures were incubated for 30 minutes at room temperature with the
avidin-biotin-peroxidase complex (1:100; Vector Laboratories, Bur-
lingame, CA, http://www.vectorlabs.com). Peroxidase activity was
revealed by the 3,3-diaminobenzidine chromogen (0.025%; Sigma-
Aldrich) intensified with 0.08% NiCl2 in 30 mM Tris-HCl (pH 7.6)
buffer containing 0.003% H2O2. The cell preparations were then
dehydrated in ethanol (70%, 2 minutes; 80%, 2 minutes; 90%, 2
minutes; 95%, 2 minutes; 100%, 2 minutes), cleared in xylene (3
minutes), and mounted using DEPEX mounting medium (Sigma-
Aldrich). Photomicrographs of TUNEL were recorded using a di-
gital camera (Axiocam HRC; Carl Zeiss, Go¨ttingen, Germany,
http://www.zeiss.com) adapted to an Axioskop 2 Plus fluorescent
microscope (Carl Zeiss).
Cell Proliferation Studies
To investigate the effect of TNF- on cell proliferation, SVZ cells
were exposed to 10 M 5-bromo-2-deoxyuridine (BrdU) (Sigma-
Aldrich) for the last 4 hours of each TNF- treatment (48 hours or
7 days). Then, SVZ cells were fixed in 4% PFA for 30 minutes and
rinsed for 30 minutes in 0.15 M PBS, at room temperature. BrdU
was then unmasked following successive passages in 1% Triton
X-100 for 30 minutes at room temperature, ice-cold 0.1 M HCl for
20 minutes, and finally 2 M HCl for 40 minutes at 40°C. Following
neutralization in sodium borate buffer (0.1 M Na2B4O710H2O, pH
8.5; Sigma-Aldrich) for 15 minutes at room temperature, slices were
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rinsed in PBS, and nonspecific binding sites were blocked with 3%
bovine serum albumin (BSA; Sigma-Aldrich) and 0.3% Triton
X-100 in PBS for 30 minutes at room temperature. SVZ cultures
were then incubated overnight at 4°C with the primary rat mono-
clonal anti-BrdU antibody (1:50; Oxford Biotechnology, Raleigh,
NC) in PBS containing 0.1% Triton X-100 and 0.3% BSA. After a
rinse in PBS, SVZ cultures were incubated with a secondary anti-rat
IgG labeled with Alexa Fluor 594 (1:200; Molecular Probes, Eu-
gene, OR, http://probes.invitrogen.com) for 1 hour at room temper-
ature. After an additional rinse in PBS, SVZ cell nuclei were stained
with Hoechst 33342 (Molecular Probes) (2 g/ml in PBS containing
0.25% BSA) for 5 minutes at room temperature. Finally, the prep-
arations were mounted using DakoCytomation fluorescent medium
(DakoCytomation, Carpinteria, CA, http://www.dakocytomation.
com). Fluorescent images were recorded using a confocal micro-
scope (LSM 510 Meta; Carl Zeiss) or an Axioskop 2 Plus fluores-
cent microscope (Carl Zeiss).
Immunocytochemical Staining for Phenotype
Discrimination and Cell Signaling
After fixation in 4% PFA for 30 minutes at room temperature, SVZ
cells were permeabilized, and nonspecific binding sites were
blocked with 0.25% Triton X-100 and 3% BSA dissolved in 0.15 M
PBS for 30 minutes at room temperature. SVZ cells were subse-
quently incubated overnight at 4°C with the following primary
antibodies, all of which had been prepared in PBS containing 0.1%
Triton X-100 and 0.3% BSA: mouse monoclonal anti-MAP-2 (1:
200; Sigma-Aldrich), mouse monoclonal anti-NeuN (1:100;
Chemicon, Temecula, CA, http://www.chemicon.com), mouse
monoclonal anti-TNFR1 (1:100; R&D Systems), mouse mono-
clonal anti-TNFR2 (1:100; R&D Systems), rabbit polyclonal anti-
phospho-(Thr183/Tyr185)-SAPK/JNK (1:100; Cell Signaling Tech-
nology, Danvers, MA, http://www.cellsignal.com), or mouse
monoclonal anti- ( 46) (1:800; Cell Signaling Technology).
Thereafter, the coverslips were rinsed in PBS and incubated for 1
hour at room temperature with the appropriate secondary antibod-
ies: anti-rabbit IgG labeled with Alexa Fluor 488 (1:200) or with
Alexa Fluor 594 (1:200) or anti-mouse IgG labeled with Alexa
Fluor 594 (1:200) (all from Molecular Probes). After an additional
rinse in PBS, SVZ cell nuclei were stained with Hoechst 33342 (2
g/ml in PBS containing 0.25% BSA) for 5 minutes at room
temperature. Finally, the preparations were mounted using Dako-
Cytomation fluorescent medium. Fluorescent images were recorded
using a confocal microscope (LSM 510 Meta; Carl Zeiss) or an
Axioskop 2 Plus fluorescent microscope (Carl Zeiss).
Single-Cell Calcium Imaging
To determine the functional differentiation pattern of SVZ cells, we
analyzed the variations of intracellular calcium-free levels ([Ca2]i)
in single cells following stimulation with 50 mM KCl or 100 M
histamine (Sigma-Aldrich) [38]. KCl depolarization causes an in-
crease in [Ca2]i in neurons [39], whereas stimulation with hista-
mine leads to an increase in [Ca2]i in stem/progenitor cells [40].
SVZ cultures were loaded for 40 minutes with 5 M Fura-
2/AM (Molecular Probes), 0.1% fatty acid-free BSA, and 0.02%
pluronic acid F-127 (Molecular Probes) in Krebs solution (132 mM
NaCl, 4 mM KCl, 1.4 mM MgCl2, 1 mM CaCl2, 6 mM glucose, 10
mM HEPES, pH 7.4), in an incubator with 5% CO2 and 95%
atmospheric air at 37°C. After a 10-minute postloading period at
room temperature in the same medium without Fura-2 and pluronic
acid, to obtain a complete hydrolysis of the probe, the glass cover-
slip was mounted on an RC-20 chamber in a PH3 platform (Warner
Instruments, Hamden, CT, http://www.warneronline.com) on the
stage of an inverted fluorescence microscope (Axiovert 200; Carl
Zeiss). Cells were continuously perfused with Krebs solution and
stimulated by applying high-potassium Krebs solution (containing
50 mM KCl, isosmotic substitution with NaCl) or 100 M hista-
mine. Solutions were added to the cells by a fast-pressurized (95%
air, 5% CO2 atmosphere) system (AutoMate Scientific, Inc., Berke-
ley, CA, http://www.autom8.com). The variations of [Ca2]i were
evaluated by quantifying the ratio of the fluorescence emitted at 510
nm following alternate excitation (750 milliseconds) at 340 and 380
nm, using a Lambda DG4 apparatus (Sutter Instrument, Novato,
CA, http://www.sutter.com) and a 510 nm band-pass filter (Carl
Zeiss) before fluorescence acquisition with a 40 objective and a
CoolSNAP digital camera (Roper Scientific, Trenton, NJ, http://
www.roperscientific.com). Acquired values were processed using
the MetaFluor software (Universal Imaging Corp., West Chester,
PA, http://www.moleculardevices.com). Histamine/KCl values for
Fura-2 ratio were calculated to determine the extent of neuronal
maturation in cultures.
Isolation of Total RNA from SVZ Cells
Total RNA was isolated from SVZ cells and murine spleen cells,
using TRI Reagent (Sigma-Aldrich) according to the manufactur-
er’s instructions. Cells were gently homogenized in guanidium
thiocyanate and phenol and allowed to stand at room temperature to
secure the complete dissociation of nucleoprotein complexes. Chlo-
roform was added, allowing a clear isolation of RNA in the resultant
aqueous phase. Then, the RNA was precipitated with isopropanol
and the pellet was washed with 75% (vol/vol) ethanol, redissolved
in diethylpyrocarbonate-treated water, and stored at 80°C.
The total amount of RNA was quantified by optical density
(OD) measurements at 260 nm, and the purity was evaluated by
measuring the ratio of OD at 260 and 280 nm (RNA/DNA calcu-
lator GeneQuant II; Amersham, Uppsala, Sweden, http://www.
amersham.com). In addition, RNA quality was assessed by gel
electrophoresis.
Reverse Transcription-Polymerase Chain Reaction
Analysis
mRNA expression of TNFR1 and TNFR2 was determined by re-
verse transcription (RT)-polymerase chain reaction (PCR). First,
cDNA was obtained from the transcription of 2 g of RNA using
avian microblastosis virus reverse transcriptase and oligo-p(dT)15
primers (Roche Molecular Biochemicals, Indianapolis, http://www.
roche-applied-science.com). PCR was performed in a 50-l reac-
tion system (Roche Molecular Biochemicals) containing 5 l of
template cDNA, 1 l of deoxynucleotide mix, 5 l of 10 PCR
buffer, 0.2 l of upstream primer, 0.2 l of downstream primer, a
variable volume of water, and 0.25 l of DNA-free sensitive Taq
DNA polymerase (35 cycles of 95°C for 30 seconds, 53°C/58°C
[TNFR1/TNFR2] for 30 seconds, and 72°C for 30 seconds; Bioron
GmbH, Ludwigshafen, Germany, http://www.bioron.net). Primers
used in PCRs were as follows: TNF- receptor 1, forward primer,
5-CCG GGC CAC CTG GTC CG-3, and reverse primer, 5-CAA
GTA GGT TCC TTT GTG-3; TNF- receptor 2, forward primer,
5-CTC GCG CTG TTC GAA CTG-3, and reverse primer, 5-GGT
ATA CAT GCT TGC CTC ACA GTC-3 (MWG Biotech, Ebers-
berg, Germany, http://www.mwg-biotech.com) [26]; and -actin,
forward primer, 5-GAC TAC CTC ATG AAG ATC CT-3, and
reverse primer, 5-ATC TTG ATC ATG GTG CTG-3 (35 cycles of
95°C for 60 seconds, 55°C for 60 seconds, and 72°C for 60
seconds).
PCR products of each sample were subjected to electrophoresis
in a 1.5% agarose gel and stained with ethidium bromide. Negative
controls were performed without RNA sample, which was replaced
by water. Positive controls were total murine spleen mRNA sam-
ples. Photographs were taken in a Versa-Doc Imaging System
(model 3000; Bio-Rad, Hercules, CA, http://www.bio-rad.com).
Statistical Analysis
In all experiments, measurements were performed in the border of
SVZ neurospheres where migrating cells form a cell monolayer. For
SCCI experiments, the percentage of neuronal-like responding cells
(with a histamine/KCl ratio below 0.8) was calculated on the basis
of one microscopic field per coverslip, containing approximately
100 cells (magnification, 40). Percentages of neuronal-like re-
sponding cells in untreated control cultures were set to 100%. Each
experimental condition was assayed in three different coverslips.
Except where otherwise specified, the experiments were replicated
in three independent culture preparations. Percentages of NeuN,
BrdU, or TUNEL immunoreactive cells in SVZ cell cultures were
calculated from cell counts in five independent microscopic fields in
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each coverslip with a 40 objective (approximately 200 cells per
field). Quantification of P-SAPK/JNK positive nuclei per neuro-
sphere (at 15 minutes) was done in two independent culture prep-
arations in at least 20 nonoverlapping fields, using confocal digital
images (magnification, 40; LSM 510 Meta; Carl Zeiss). Quanti-
fication of the number of neuritic ramifications positive for P-
SAPK/JNK per neurosphere, as well as the total neuritic length and
growth cone-like structures per neurosphere (at 6 hours), was per-
formed in five independent culture preparations in approximately 20
nonoverlapping fields per coverslip using digital images (magnifi-
cation, 20). Software used was Axiovision, release 4.6 (Carl
Zeiss).
Data are expressed as means  SE of mean (SEM). Statistical
significance was determined by using the unpaired two-tailed Stu-
dent’s t test, with p  .05 considered to represent statistical signif-
icance.
RESULTS
SVZ Cells Express Both TNFR1 and TNFR2
To investigate the expression of both TNFR1 and TNFR2, we
performed RT-PCR [26] and immunocytochemistry in SVZ
cultures. As shown in Figure 1, both receptors were detected by
RT-PCR analysis (n  3 for each receptor) (Fig. 1A) and by
standard immunocytochemistry in differentiated and undiffer-
entiated SVZ cells (Fig. 1C, 1D, respectively). Positive and
negative controls were performed to confirm the specificity of
the primers and of the primary antibodies used for the detection
of both TNF- receptors. In accordance with the higher levels of
TNFR1 compared with TNFR2 detected by either RT-PCR and
immunocytochemistry, clear Western blotting bands corre-
sponding to the expression of TNFR1 were detected in SVZ
explants and neurospheres (Fig. 1B).
TNF- Induces Neuronal Differentiation Via TNFR1
Activation
To functionally evaluate neuronal differentiation in SVZ cul-
tures, we established a method based on variations of [Ca2]i in
single cells in response to KCl or histamine (Fig. 2B–2D) [38].
Membrane depolarization of neuronal cells following exposure
to high KCl concentrations leads to the opening of voltage
sensitive calcium channels and massive influx of calcium into
the cytoplasm [39], whereas stimulation with histamine specif-
ically triggers an increase in [Ca2]i in immature SVZ cells
[40]. In view of these findings, we demonstrated that the ratio of
responses due to histamine or KCl exposure (Hist/KCl) differs
significantly between cell type groups, with a low Hist/KCl ratio
(below 0.8) being characteristic of SVZ-derived neurons (Fig.
2C, 2D) [38].
Thus, to investigate whether TNF- might influence the
capacity of SVZ cells to differentiate into functional neuronal
cells, 6–8-day-old SVZ neurospheres were allowed to develop
on poly-D-lysine-coated coverslips for 7 days in the presence of
recombinant mouse (1 or 10 ng/ml) or human (1 ng/ml) TNF-.
Adherence on a poly-D-lysine substrate and withdrawal of
growth factors are necessary steps to promote outward cell
migration and differentiation of progenitor cells at the border of
the neurospheres [41]. At the border of neurospheres, migrating
cells emerged, forming a cell monolayer, where all the measure-
ments of [Ca2]i and cell countings of immunostainings were
performed. At the end of TNF- treatments, the SVZ cells were
loaded with the Fura-2/AM calcium probe, perfused continu-
ously for 15 minutes with Krebs solution, and briefly (2 min-
utes) stimulated with 50 mM KCl or 100 M histamine, as
depicted in Figure 2B.
Interestingly, the majority of TNF-treated SVZ cells dis-
played an increase in the [Ca2]i in response to KCl but not to
histamine stimulation, consistent with a neuronal-like profile
(Fig. 3A). In contrast, control, nontreated cultures showed a
predominant immature-like profile, characterized by an increase
in [Ca2]i in response to histamine but a small response or no
response to KCl stimulation (Fig. 3A). Quantification of the
percentage of cells displaying a low histamine/KCl ratio showed
that TNF- induced increases of approximately threefold
(308.9%  46.52%; 928 cells analyzed; p  .001) and approx-
imately twofold (203.5% 38.9%; 325 cells analyzed; p .05)
in the proportion of neuronal-like responding SVZ cells, for 1
and 10 ng/ml, respectively, compared with control, nontreated
cells (1,930 cells analyzed) (set to 100%) (Fig. 3A). To deter-
mine which receptor mediates the proneurogenic effect of
TNF-, SVZ cells were coincubated for 7 days with 1 ng/ml
TNF- and with neutralizing antibodies to each TNF- receptor.
We found that the proneurogenic effect mediated by 1 ng/ml
TNF- was inhibited by coincubation with the neutralizing
Figure 1. SVZ cells express both TNFR1 and TNFR2. (A): reverse
transcription-polymerase chain reaction detection of mRNA for TNFR1
and TNFR2 in SVZ neurospheres. Left lane is a DNA ladder to indicate
size of amplified products (TNFR1, approximately 300 base pairs [bp];
TNFR2, approximately 233 bp). Positive controls () were done in total
murine spleen mRNA. (B): Detection of TNFR1 protein by Western
blotting in hippocampus, SVZ tissues, and SVZ neurospheres. Anti-
TNFR1 antibody was purchased from Santa Cruz Biotechnology Inc.
(Santa Cruz, CA, http://www.scbt.com) and diluted at 1:200. (C, D):
Representative fluorescent confocal photomicrographs depicting
TNFR1 and TNFR2 immunoreactivity (red staining for both receptors)
in SVZ cells migrating out of a neurosphere 2 days after plating (C) and
in mechanically dissociated cells from SVZ neurospheres, plated 1 hour
before fixation (D). Hoechst 33342 staining (blue) was used to visualize
cell nuclei. Scale bars  10 m. Abbreviations: SVZ, subventricular
zone; TNFR, tumor necrosis factor receptor.
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anti-TNFR1 antibody (54.8% 34.2%; 288 cells analyzed; p
.001 vs. 1 ng/ml TNF alone) but not with the neutralizing
anti-TNFR2 antibody (368.8%  84.3%; 224 cells analyzed)
(Fig. 3A). In agreement, SVZ cultures incubated with human
recombinant TNF- (1 ng/ml), known to bind to mouse TNFR1
only [42], showed an approximately threefold increase
(323.2%  83.2%; 650 cells analyzed) in the proportion of
neuronal-like responding cells, similarly to mouse recombi-
nant TNF- (Fig. 3A). To disclose a possible effect of
endogenous secreted TNF- on SVZ cell differentiation, the
cells were treated with an anti-TNF- antibody. Neutraliza-
tion of endogenous TNF- did not significantly reduce the
percentage of neuronal-like cells in the culture (control:
100.0%  15.5%, n  7 coverslips, 528 cells analyzed;
anti-TNF- antibody alone: 92.9%  35.9%, n  4 cover-
slips, 306 cells analyzed; p  .84). Moreover, mouse recom-
binant TNF- induced increases in NeuN-immunoreactive
cells (a neuronal-specific nuclear protein present on mature
neurons) to 26% (26.4%  1.9%; 2,809 cells counted; p 
.001) and 22% (22.3%  3.1%; 4,057 cells counted; p 
.001) for 1 and 10 ng/ml, respectively, compared with 8%
NeuN-immunoreactive cells present in control cultures (8.5% 
1.0%; in 8,446 cells counted). Interestingly, no significant
effect was observed in SVZ cells treated with 0.3 or 100
ng/ml TNF- (Fig. 3B). Immunoreactivity against MAP-2, a
microtubule-associated protein present in dendrites of mature
neurons, was also increased in SVZ cell cultures treated with
both 1 and 10 ng/ml mouse recombinant TNF-, compared
with the control (Fig. 3C). TNF- treatment had no effect on
the capacity of the cells to differentiate into the glial lineage,
as determined by immunostaining for glial fibrillary acidic
protein (data not shown). Together, these results show that
when exogenously added at 1 and 10 ng/ml, TNF- induces
neuronal differentiation in SVZ cells via TNFR1 activation.
Figure 2. Experimental protocol for the functional evaluation of neuronal differentiation in mouse SVZ cell cultures. (A): Schematic representation
of the protocol used for studying the effects of TNF- on SVZ cell cultures. Dashed line, exposure to TNF-. (B): SVZ cultures were perfused
continuously in Krebs solution for 15 min and stimulated for 2 min (from min 5 to min 7) with 50 mM KCl and for 2 min (from min 10 to min 12)
with 100 M Hist. (C): Pseudocolor images of a single-cell calcium imaging experiment obtained by ratio of fluorescence emitted at 510 nm
following excitation at 340 or 380 nm. Images were taken from the same field and obtained at different time points, upon Krebs solution (basal), KCl,
and Hist perfusion. Neurons increased [Ca2]i following KCl (red arrowhead), and immature cells increased [Ca2]i following Hist perfusion (yellow
arrowhead). Scale of non-normalized ratio of fluorescence intensity is indicated at the right; blue and red indicate low and high ratios, respectively.
Observed fields contained approximately 100 cells. Scale bar 50 m. (D): Profiles of five representative cells presenting an immature-like response
(left graph) or a neuronal-like response (middle graph) in SVZ culture and in a culture of hippocampal neurons as a positive control to show neuronal
profile of responses (right graph). Additional details are given in Agasse et al. [38]. Abbreviations: h, hours; Hist, histamine; min, minutes; N,
neurosphere; SVZ, subventricular zone; TNF-, tumor necrosis factor .
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TNF- Modulates Both Cell Proliferation and
Survival
To investigate the role of TNF- on cell proliferation and
survival, SVZ cell cultures were exposed to TNF- for 48 hours
or 7 days, and BrdU and TUNEL staining was performed (Fig.
2A). SVZ cells exposed for 48 hours to 1 ng/ml but not to 10
ng/ml TNF- displayed an approximately 1.5-fold increase
(6.3%  0.6%; n  6 coverslips; 3,987 cells counted; p  .05)
in the percentage of BrdU-positive cells compared with control
cultures (4.1%  0.6%; n  6 coverslips; 4,370 cells counted)
(Fig. 4A). No significant effect on cell proliferation was ob-
served in 0.3 and 100 ng/ml TNF--treated cells (data not
shown). Since the cells were grown under differentiation con-
ditions [41], the proliferative effect mediated by exposure to 1
ng/ml TNF- for 48 hours was not observed following 7 days of
incubation (control: 2.3%  0.08%; n  3 coverslips, TNF-:
1.9%  0.3%; n  6 coverslips, p  .05), probably because of
a shift from cell proliferation to neuronal differentiation (de-
scribed below).
Moreover, we also performed TUNEL staining to examine
the effects of TNF- on cell apoptosis. Exposure of SVZ cells
to 10 and 100 ng/ml TNF- for 48 hours significantly increased
the percentage of TUNEL-positive apoptotic cells to 21%
(21.1%  1.6%; n  12 coverslips; 6,511 cells counted; p 
.001) and to 25% (25.7%  2.9%; n  8 coverslips; 4,852 cells
counted; p .001), compared with 13% of apoptotic cells in the
control cultures (13.1%  1.1%; n  13 coverslips; 7,909 cells
counted) (Fig. 4B). No significant effect on cell death was
Figure 3. TNF induces neuronal differentiation in mouse subventricular zone (SVZ) cell cultures via TNFR1 activation. (A): Bar graph depicts the
percentages of neuronal-like responding cells in SVZ control cultures (no drug exposure) and in cultures exposed to 1 or 10 ng/ml mTNF or to 1 ng/ml
hTNF for 7 days. In another set of experiments, SVZ cells were coincubated with 1 ng/ml mouse TNF and blocking Abs to TNFR1 (TNF  Ab
TNFR1) or TNFR2 (TNF  Ab TNFR2). Data are expressed as a mean  SEM (n  5–26). , p  .05; , p  .001 using the unpaired Student’s
t test for comparison with SVZ control cultures (set to 100%);, p .001 using the unpaired Student’s t test for comparison with 1 ng/ml mTNF.
Shown are representative single-cell calcium imaging profiles of response of 15 cells in a control culture and in a culture treated with 1 ng/ml mTNF.
(B): Bar graph depicts the percentages of NeuN-positive cells, expressed as percentage of the total number of cells per culture, in control cultures
and in cultures treated with mouse TNF for 7 days. Data are expressed as a mean  SEM (n  4–13). , p  .001 using the unpaired Student’s
t test for comparison with SVZ control cultures. Representative fluorescent photomicrographs of NeuN-positive neurons (red nuclei) and Hoechst
33342 staining (blue nuclei) in SVZ cultures. Scale bars 50 m. (C): Representative fluorescent photomicrographs of MAP-2-positive neurons (red
staining) and Hoechst 33342 staining (blue nuclei) in a control culture and in cultures exposed to 1 or 10 ng/ml TNF for 7 days. Scale bars  50 m.
Abbreviations: Ab, antibody; Hist, histamine; hTNF, human tumor necrosis factor ; mTNF, mouse tumor necrosis factor ; NeuN, neuronal nuclear
protein; TNF, tumor necrosis factor ; TNFR, tumor necrosis factor receptor.
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observed in 0.3 and 1 ng/ml TNF-treated cells (Fig. 4B). To
ascertain that the increase in TUNEL-positive nuclei is consis-
tent with an induction of apoptosis due to the incubation with 10
ng/ml TNF-, SVZ cells were coincubated with TNF- and 25
M zVAD-fmk, a proapoptotic caspase inhibitor. As expected,
zVAD-fmk alone inhibited the basal cell apoptosis inherent in
control cultures (5.1%  0.9%; n  3 coverslips; 2,234 cells
counted; p  .01 vs. control; the zVAD-fmk solution vehicle,
dimethyl sulfoxide, was without effect). Moreover, the toxic
effect mediated by 10 ng/ml TNF- was inhibited when SVZ
cells were coincubated with 25 M zVAD-fmk (7.2%  0.6%;
n  6 coverslips; 4,193 cells counted; p  .001 vs. 10 ng/ml
TNF alone and p  .01 vs. control) (Fig. 4B). Taken together,
these results suggest that 1 ng/ml TNF- induces cell prolifer-
ation, whereas at high concentrations (10 and 100 ng/ml) TNF-
triggers cell apoptosis.
TNF- Activates the SAPK/JNK Pathway in
-Positive Axons
Several studies have shown that MAP kinase pathways, in partic-
ular the SAPK/JNK pathway, play a key role in the signaling
transduction of TNF- [43, 44]. To investigate whether the SAPK/
JNK signaling pathway was activated by TNF-, SVZ cell cultures
were exposed to TNF- for 15 minutes or 6 hours (Fig. 2A). At the
end of each treatment, immunocytochemistry against the phosphor-
ylated (activated) forms of the JNK kinase (i.e., P-SAPK/JNK) was
performed using an antibody that specifically detects endogenous
levels of p46 and p54 of the three JNK isoforms (i.e., JNK1, JNK2,
and JNK3). Exposure of SVZ cell cultures to 1 or 10 ng/ml TNF-
for 15 minutes induced an increase in P-SAPK/JNK-positive nuclei
per neurosphere (1 ng/ml TNF, 26.7  2.7, n  3 coverslips, p 
.001; 10 ng/ml TNF, 33.2  4.7, n  2 coverslips, p  .05)
compared with control cultures (1.5 0.3; n 2 coverslips) (Fig.
5A, top row). Interestingly, exposure of SVZ cells to 1 or 10 ng/ml
TNF- for 6 hours (but not for 15 minutes) induced a robust
P-SAPK/JNK immunoreactivity in growth cone-like projections
and in neurites emerging from the neurospheres and not in the
nucleus (Fig. 5A, middle row). Control cultures showed a diffuse or
faint P-SAPK/JNK staining throughout the cytoplasm, with only a
few positive growth cone-like structures immunoreactive to P-
SAPK/JNK and little or no nuclear localization of P-SAPK/JNK
(Fig. 5A, top and middle rows). Moreover, quantification of the
number of ramifications per neurosphere, as well as the total length
of ramifications and growth cone-like projections/neurites per neu-
rosphere, showed that 1 ng/ml TNF- induced an approximately
fourfold increase in both parameters, compared with control, non-
treated cultures (Fig. 5A, bar graphs). This effect was lost at 100
ng/ml concentration. All the measurements were performed at the
border of neurospheres, where the P-SAPK/JNK-immunoreactive
fibers emerge. To investigate whether P-SAPK/JNK immunoreac-
tivity was associated with axons, double immunocytochemistry
against P-SAPK/JNK and , a microtubule-associated protein that
induces bundling and stabilization of axonal microtubules, was
performed. As shown in Figure 5B, P-SAPK/JNK immunoreactiv-
ity, induced by exposure of SVZ cells to 1 and 10 ng/ml TNF- for
6 hours, was localized in -positive axons. Together, these data
suggest that low concentrations (1 ng/ml) of TNF- promote axo-
nogenesis and neuronal maturation of SVZ cell cultures.
DISCUSSION
The major finding of the present work is that TNF-, specially
at a concentration of 1 ng/ml, induces neurogenesis in mouse
SVZ cell cultures, suggesting that some inflammatory mediators
may promote brain repair following injury. We observed that 1
and 10 ng/ml TNF- induced an increase in the percentage of
cells with a neuronal-like profile (Hist/KCl below 0.8), thus
responding more to KCl and less to histamine compared with
the control, nontreated cultures. Moreover, TNF- induced an
increase in the percentage of NeuN-positive neurons, as well as
the immunoreactivity to the neuronal marker MAP-2. Our data
suggest that the proneurogenic effect mediated by TNF- in-
volves the activation of the TNFR1, since exposure of SVZ cells
to human TNF- induced an increase in the percentage of cells
with a neuronal-like profile, similar to the percentage increase
mediated by mouse recombinant TNF- and neutralizing anti-
bodies to TNFR1, but not TNFR2, inhibited the proneurogenic
effect mediated by 1 ng/ml TNF-. Nevertheless, we cannot
exclude a possible involvement of the TNFR2 in other effects,
such as survival and proliferation. To date, studies on the effects
of TNF- on neural stem/progenitor cells have yielded conflict-
ing results. Only a few reports have shown a proneurogenic
effect mediated by TNF-, although this effect was associated
with AIDS dementia and not directly with brain repair [33, 34].
Moreover, other members of the TNF receptors family, such as
p75 and Fas, can be also involved in nonapoptotic pathways,
such as neurite outgrowth and regeneration [45, 46].
Using a BrdU incorporation assay, our results provide evi-
dence that TNF- positively regulates proliferation in SVZ cells
treated with 1 ng/ml but not those treated with 10 ng/ml TNF-.
In line with our results, it was reported by others that endoge-
Figure 4. TNF differentially modulates cell proliferation and survival
in mouse subventricular zone (SVZ) cell cultures. (A): Bar graph
depicts the number of BrdU-positive cells, expressed as percentage of
the total number of nuclei per culture, in control cultures and in cultures
exposed to 1 or 10 ng/ml TNF for 48 hours. Data are expressed as a
mean SEM (n 3–6). Shown is a representative fluorescent confocal
photomicrograph of BrdU (red nuclei) and Hoechst 33342 staining (blue
nuclei) in a control culture. Scale bar  20 m. (B): Bar graph depicts
the number of TUNEL-positive nuclei, expressed as percentage of the
total number of nuclei, in control cultures and in cultures exposed to
TNF for 48 hours. Data are expressed as a mean  SEM (n  4–13).
Shown is a representative transmission photomicrograph of TUNEL
staining (black nucleus) in a control culture. Scale bar  50 m. , p 
.05; , p  .01; , p  .001 using the unpaired Student’s t test for
comparison with SVZ control cultures; EEE, p  .001 using the
unpaired Student’s t test for comparison with 10 ng/ml TNF alone.
Abbreviations: BrdU, 5-bromo-2-deoxyuridine; TNF, tumor necrosis
factor ; TUNEL, terminal deoxynucleotidyl transferase dUTP nick-end
labeling; ZVAD, z-Val-Ala-DL-Asp (OMe)-fluoromethylketone.
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nous TNF- promotes proliferation of oligodendrocyte progen-
itors in a mouse model of demyelination [32], as well as pro-
liferation of neural progenitors residing in the SVZ/ventricular
zone following TNF- injection into the lateral ventricle of
adult rat [30]. Thus, TNF- is involved in regulating the turn-
over of neural stem/progenitor cells.
Because of the presence of the intracellular regions called death
domains in the TNFR1, we hypothesize that high TNF- concen-
trations could induce cell death. Thus, as assessed by TUNEL, 10
and 100 ng/ml TNF-, but not 0.3 and 1 ng/ml TNF-, induced cell
death compared with the control cultures. These results suggest that
TNF- at lower concentrations (0.3 and 1 ng/ml) does not reach a
Figure 5. TNF induces activation of the c-Jun N-terminal kinase (JNK) MAPK pathway on growing axons. (A): Top row depicts representative fluorescent
confocal photomicrographs of the P-SAPK/JNK (red) and Hoechst 33342 staining (blue nuclei) in control cultures and in cultures exposed to 1 or 10 ng/ml TNF
for 15 min. Scale bars  10 m. Arrows depict P-SAPK/JNK immunoreactivity in the nucleus. Middle row depicts representative fluorescent confocal
photomicrographs of the P-SAPK/JNK (green) and Hoechst 33342 staining (blue nuclei) in control cultures and in cultures exposed to 1 or 10 ng/ml TNF, for 6 h.
Scale bars  20 m. Arrows depict P-SAPK/JNK immunoreactivity in growth cone-like structures and in neurites. (Aa, Ab): High-magnification fluorescent
confocal photomicrographs of a growth cone-like structure (Aa) and a positive cell (Ab) to the P-SAPK/JNK staining in subventricular zone (SVZ) cultures treated
with 10 ng/ml TNF for 6 h. Scale bars 10 m. Bar graphs depict number of ramifications and total length (m) of the ramifications per neurosphere. Data are
expressed as a meanSEM. Measurements were done in approximately 20 nonoverlapping fields in each coverslip from five independent culture preparations using
digital images (magnification, 20). , p  .05; , p  .01 using the unpaired two-tailed Student’s t test for comparison with SVZ control cultures. (B):
Representative fluorescent confocal photomicrographs of the P-SAPK/JNK (green),  (red), and Hoechst 33342 (blue) staining in control cultures and in cultures
exposed to 1 or 10 ng/ml TNF for 6 h. Scale bars 20m. Arrows depict P-SAPK/JNK and  double labeling. Abbreviations: h, hours; min, minutes; TNF, tumor
necrosis factor .
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threshold for activation of death domains; an alternative, but not
mutually exclusive, scenario is that TNF- may activate other
downstream signaling pathways that do not necessarily induce cell
death, depending on cell phenotype/differentiation. Accordingly,
Cacci et al. [26] showed that TNF- released from activated
microglia, as well as exogenous added TNF-, at high concentra-
tions (20 ng/ml), can promote the death of newly formed hip-
pocampal progenitors in vitro [26]. Interestingly, and in accordance
with our data, it was also reported that TNF- (10 ng/ml) was
cytotoxic to SVZ neurospheres from adult mice [29].
To investigate the involvement of the SAPK/JNK pathway in
response to TNF-, we performed immunocytochemistry using
specific antibodies against the phosphorylated forms of SAPK/JNK
kinase. We observed that TNF- induced a robust change, in a
time-dependent manner, of the subcellular localization of the acti-
vated (phosphorylated) forms of JNK, in SVZ cultures. After 15
minutes of incubation of SVZ cells with 1 and 10 ng/ml TNF-, we
observed P-SAPK/JNK immunoreactivity translocation into the
nucleus in a significant number of SVZ cells. However, after 6
hours of incubation at both TNF- concentrations, a robust P-
SAPK/JNK immunoreactivity was observed on -positive axons
and growth cone-like structures extending out of neurospheres, but
not in the nucleus. Moreover, TNF- treatment increased the total
length and the number of P-SAPK/JNK-positive ramifications.
SAPK/JNK kinases are strongly activated in response to cytokines
and stress stimuli [47, 48]. In our model, JNK is initially activated
following TNF- exposure and translocates to the nucleus, where
it can phosphorylate and activate several transcription factors, in-
cluding c-Jun [49–51]. Activation of the JNK pathway has been
associated with response to a diversity of stresses, and proapoptotic
mechanisms [44]. Indeed, c-jun has been shown to transduce cell
death signals [52–54]. However, the JNK pathway appears to
mediate both proapoptotic and antiapoptotic functions, depending
on the cell type, nature of stimulus, and strength of its activation
[55]. Indeed, a growing body of literature supports a role of JNK in
cell proliferation, survival, and differentiation [54–56]. It was
shown that the JNK1 gene is involved in the repression of Wnt
expression (Wnt is a known inhibitor of embryonic stem [ES] cell
neurogenesis) and thus promotes neural differentiation of murine
ES cells [57]. Also, disruption of the JNK pathway-specific scaf-
fold protein JSAP1 in murine ES cells reduced neurogenesis in
vitro [58]. Moreover, in differentiated neurons from wild-type
embryoid bodies, JSAP1 was localized in the soma, neurites, and
growth cone-like structures, and neurite outgrowth from the
JSAP1-null embryoid bodies was apparently less prominent [58].
Recently, Kim et al. showed that interferon- promotes neuronal
differentiation characterized by neurite outgrowth and expression
of neuronal markers of a neural progenitor cell line via the JNK
pathway [59]. These reports are in agreement with our results
showing that after 6 hours of incubation with TNF-, P-SAPK/
JNK immunoreactivity is found in -positive axons and growth
cone-like structures. Accordingly, 1 ng/ml TNF- promotes both
differentiation and maturation. Indeed, the increase in the number
of NeuN-positive neurons following TNF- treatment for 7 days
(Fig. 3B) suggests an increase in neuronal commitment of progen-
itors. Moreover, SVZ cultures treated for 6 hours with TNF-
display a robust increase in P-JNK immunoreactivity in -positive
axons, consistently with neuronal maturation of neuroblasts. P-JNK
immunoreactivity is closely associated with new differentiating
axons (-positive) and is not associated with fully differentiated
neurons. Thus, activated JNK also targets nonnuclear substrates,
such as cytoskeletal proteins, neurofilaments, and actin, and so can
modify cytoskeletal regulation, cell motility, axonogenesis, and
neuronal polarization [60–66].
In the intact brain, concentrations of TNF- are low or
barely detectable [67]. In accordance, in our experimental con-
ditions, we were not able to find any effect of TNF- at a 0.3
ng/ml concentration on cell proliferation and differentiation.
Furthermore, in SCCI studies, we incubated SVZ for 7 days
with a neutralizing anti-TNF- antibody to neutralize the bio-
logical effects of endogenously produced TNF-. Here again,
levels of functional differentiation were similar to control levels,
demonstrating that at physiological (i.e., low) levels, TNF-
modulates SVZ dynamics poorly. However, following brain
injury or infection, circulating levels of TNF- dramatically
increase to levels close to the range of concentrations that we
used in the present study (1–100 ng/ml) [67, 68]. This suggests
that these concentrations are of robust pathophysiological rele-
vance, and so TNF- modulates neurogenesis mainly following
brain injury and may be part of the repertoire of repairing factors
released in the microenvironment that promote neuronal re-
placement from the SVZ pool of stem/progenitor cells.
CONCLUSION
The proneurogenic effect of TNF- may open new perspectives
for brain repair, highlighting the role of proinflammatory cyto-
kines in neurogenesis and neuronal replacement in the damaged
brain. We are currently conducting new studies in which SVZ
neurospheres pretreated with 1 ng/ml TNF- are transplanted
into the hippocampal CA3 subfield in a rodent model of tem-
poral lobe epilepsy. Our preliminary results (data not shown)
reveal that TNF--treated SVZ cells differentiate to some extent
to doublecortin-positive neuroblasts. Thus, a better understand-
ing of the effects of inflammatory conditions after brain injury
or infection in neural stem cells, as well as a better knowledge
of the signal transduction pathways activated in neurogenic and
inflammatory conditions, will allow the development of new
strategies to enhance neuronal differentiation and replacement
using SVZ stem cells.
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